title: Ifosfamide encephalopathy.
abstract: Encephalopathy is a potentially fatal toxicity of ifosfamide. Clinical manifestations of encephalopathy range from fatigue and confusion to coma and death. Early identification of this toxicity and prompt cessation of ifosfamide are the essential elements in the management of ifosfamide encephalopathy. Accurate prediction of this toxicity is often difficult. Based on the limited available evidence, methylene blue, an electron acceptor, may have a role in the treatment and the prevention of neurotoxicity. This paper reviews the current understanding of ifosfamide encephalopathy.
authors.affiliation: Department of Oncology, Addenbrooke's Oncology Centre, Hills Road, Cambridge CB2 2QQ, UK. tvajith@hotmail.com
authors.forename: T
authors.initials: T
authors.lastname: Ajithkumar
authors.forename: C
authors.initials: C
authors.lastname: Parkinson
authors.forename: F
authors.initials: F
authors.lastname: Shamshad
authors.forename: P
authors.initials: P
authors.lastname: Murray
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects*; D020258:Neurotoxicity Syndromes / Q000209:etiology*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D007069:Ifosfamide